LIVE RESOURCE SYSTEM15 HEALTH TRACKSEVIDENCE-LED READING
0%
FOCUSED INTERVAL GUIDE

Why Pharma’s Clinical Trial Digital Projects Stall, and Where the Fixes Are Working

Large drugmakers have poured money into digital tools for clinical trials, yet many projects never deliver the speed or data quality they promised. The problem usually isn’t the software. It’s how organizations roll it out, and whom they forget to involve. Where digital programs go wrong Analysis of why big pharma digital transformation efforts fail […]

3MINUTES
455WORDS
Nov 2UPDATED
clinical trial digital transformation
READ TIME3MIN
INTERVAL ACTIVEHEALTH
BEFORE YOU START

This resource is educational and does not replace diagnosis, emergency care or personalized medical advice.

Large drugmakers have poured money into digital tools for clinical trials, yet many projects never deliver the speed or data quality they promised. The problem usually isn’t the software. It’s how organizations roll it out, and whom they forget to involve.

Where digital programs go wrong

Analysis of why big pharma digital transformation efforts fail points to a familiar set of causes: fragmented technology adoption, weak change management, little engagement with trial sites, and a mismatch between operational goals and the tools bought to meet them. A coordinator who must learn four separate systems to complete one patient visit will not call that progress.

The discussion in why Big Pharma trial digital transformation initiatives fail argues that lasting change needs cultural adaptation, redesigned workflows and measurable value, not just a software installation.

Bring sites into the design

Sites run the trials, so if their workflows aren’t part of the plan, adoption stalls. This matters more as decentralized trials and data-driven decision-making become central, since both depend on consistent data capture across many locations. Sponsors that ask sites what slows them down before choosing a tool can avoid the worst mismatches.

eSource targets a specific pain point

One approach aimed squarely at a known bottleneck is eSource, which captures clinical data directly at the point of care. That cuts out much of the manual transcription from source records into trial databases, easing workload and improving data integrity. Faster access to high-quality data then helps streamline processes across sites. This interview on how eSource redefines clinical research workflows covers the shift in detail.

Real-world data needs rules too

Novo Nordisk has outlined a strategic framework for fit-for-purpose real-world data. The emphasis falls on methodological rigor and contextual relevance, which is a polite way of saying that not every dataset suits every question. Evidence drawn from routine care can support regulatory and clinical decisions, but only when the data match the job they’re asked to do.

A practical checklist before the next rollout

Does the tool fit existing site workflows? Who owns training and support? What measurable result should appear within a year? And does it connect with systems sites already use? Honest answers to those four questions filter out many expensive mistakes.

Smaller sponsors can learn from the same pattern. A narrow tool that fixes one visible problem, such as duplicate data entry, often earns more site goodwill than a broad platform that changes everything at once. Quick wins build the trust that larger changes need later.

Conclusion

Digital transformation succeeds when it makes a coordinator’s day easier and a dataset more trustworthy. Tools that remove steps, like eSource, and frameworks that set standards, like fit-for-purpose real-world data, are better starting points than yet another stand-alone platform.

INTERVAL COMPLETE

Review the key point. Choose one useful next step.

For urgent symptoms, medication decisions or treatment choices, consult a qualified healthcare professional.